Changeflow GovPing Telecom & Technology Hybrid predictive modeling for control of cell ...
Routine Notice Added Final

Hybrid predictive modeling for control of cell culture

Favicon for changeflow.com ChangeBridge: Patent Grants - AI & Computing (G06N)
Published March 31st, 2026
Detected March 31st, 2026
Email

Summary

The USPTO granted Amgen Inc. Patent US12590283B2 covering a method of controlling cell culture processes using hybrid predictive modeling. The patent combines data-driven models (including neural networks) with first principle models in a model predictive controller to optimize physical inputs to cell culture processes. The patent includes 22 claims and names six inventors including Mohammad Rashedi and Matthew N. Demers.

What changed

The USPTO issued Patent US12590283B2 to Amgen Inc. on March 31, 2026, covering a hybrid predictive modeling system for cell culture process control. The invention combines machine learning components (G06N 3/0464, 3/084, 3/09, 20/10) with first principle models within a model predictive controller framework to predict future cell culture attributes and optimize control values for physical inputs. The patent application was filed on February 24, 2023, as Application No. 18113967.

This patent grant represents an informational intellectual property milestone rather than a regulatory compliance requirement. Biopharmaceutical manufacturers and biotechnology companies engaged in cell culture-based production should review the granted claims (22 total) for potential licensing implications or freedom-to-operate concerns. The patent does not impose compliance deadlines or regulatory obligations on third parties; it grants Amgen exclusive rights to the claimed methods in the United States.

Source document (simplified)

← USPTO Patent Grants

Hybrid predictive modeling for control of cell culture

Grant US12590283B2 Kind: B2 Mar 31, 2026

Assignee

AMGEN INC.

Inventors

Mohammad Rashedi, Hamid Khodabandehlou, Seyedehmina Rafieishishavan, Matthew N. Demers, Aditya Tulsyan, Tony Y. Wang

Abstract

A method of controlling a cell culture process uses hybrid predictive modeling in a model predictive controller. The method includes, for multiple time intervals, obtaining current values of cell culture attributes associated, and generating a control value for a physical input to the cell culture process. Generating the control value includes predicting future values of the cell culture attributes based on the current values, by using one or more data-driven models to predict future values of a first one or more attributes of the cell culture attributes, and using one or more first principle models to predict future values of a second one or more attributes of the cell culture attributes. Generating the control value also includes determining the control value by optimizing an objective function subject to the predicted future values. The method also includes using the control value to control the physical input to the cell culture process.

CPC Classifications

C12M 41/48 C12M 41/32 C12M 29/00 C12M 41/46 C12M 41/44 G01N 21/65 G06N 3/0464 G06N 3/084 G06N 3/09 G06N 20/10 G01J 3/28 G01J 3/44

Filing Date

2023-02-24

Application No.

18113967

Claims

22

View original document →

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12590283B2

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Drug manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Biotechnology Patents Process Control Systems AI/ML Systems
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Artificial Intelligence Pharmaceuticals Biotechnology

Get Telecom & Technology alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - AI & Computing (G06N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.